Lyle J. Olson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lyle J. Olson has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
Virend K. Somers
Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA
12 shared publicationsBruce D. Johnson
Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA
10 shared publications- Bruce D. Johnson
Mayo Clinic, Rochester, MN
9 shared publications - Christopher G. Scott
Mayo Clinic
9 shared publications Ivan Cundrle
Department of Anesthesiology and Intensive Care, St. Anne's University Hospital, Brno, Czech Republic; Faculty of Medicine, Masaryk University, Brno, Czech Republic; International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic
8 shared publications- Virend K. Somers
Mayo Clinic
6 shared publications
Latest Publications
- 1 October 2020
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 26 (10) , 832-840
Mitigation of Exercise Oscillatory Ventilation Score by Cardiac Resynchronization Therapy
- 1 October 2020
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 26 (10) , 832-840
Mitigation of Exercise Oscillatory Ventilation Score by Cardiac Resynchronization Therapy
- 1 June 2019
- Published by Elsevier in Clinics in Chest Medicine
- Vol. 40 (2) , 439-448
Pulmonary Limitations in Heart Failure
- 1 June 2019
- Published by Elsevier in Clinics in Chest Medicine
- Vol. 40 (2) , 439-448
Pulmonary Limitations in Heart Failure
- Open Access
- 23 June 2017
- Published by Wiley in Journal of Sleep Research
- Vol. 27 (2) , 240-243
Low leptin concentration may identify heart failure patients with central sleep apnea
Summary: Low leptin concentration has been shown to be associated with central sleep apnea in heart failure patients. We hypothesized that low leptin concentration predicts central sleep apnea. Consecutive ambulatory New York Heart Association (NYHA) classes I–IV heart failure patients were studied prospectively, including measurement of serum leptin, echocardiography and polysomnography. Sleep apnea was defined by type (central/mixed/obstructive) and by apnea–hypopnea index ≥5 by polysomnography. Subjects were divided into four groups by polysomnography: (1) central sleep apnea, (2) mixed apnea, (3) no apnea and (4) obstructive sleep apnea. Fifty‐six subjects were included. Eighteen subjects were diagnosed with central sleep apnea, 15 with mixed apnea, 12 with obstructive apnea and 11 with no sleep apnea. Leptin concentration was significantly lower in central sleep apnea compared to obstructive apnea (8 ± 10.7 ng mL−1 versus 19.7 ± 14.7 ng mL−1, P ˂ 0.01) or no sleep apnea (8 ± 10.7 ng mL−1 versus 17.1 ± 8.4 ng mL−1, P ˂ 0.01). Logistic regression showed leptin to be associated independently with central sleep apnea [odds ratio (OR): 0.19; 95% confidence interval (CI): 0.06–0.62; area under the curve (AUC): 0.80, P < 0.01]. For the detection of central sleep apnea, a cut‐off value for leptin concentration 5 ng mL−1 yielded a sensitivity of 50% and specificity of 89%. In conclusion, a low leptin concentration may have utility for the screening of heart failure patients for central sleep apnea.
- 23 June 2017
- Published by Wiley in Journal of Sleep Research
- Vol. 27 (2) , 240-243
Open AccessLow leptin concentration may identify heart failure patients with central sleep apnea
Summary: Low leptin concentration has been shown to be associated with central sleep apnea in heart failure patients. We hypothesized that low leptin concentration predicts central sleep apnea. Consecutive ambulatory New York Heart Association (NYHA) classes I–IV heart failure patients were studied prospectively, including measurement of serum leptin, echocardiography and polysomnography. Sleep apnea was defined by type (central/mixed/obstructive) and by apnea–hypopnea index ≥5 by polysomnography. Subjects were divided into four groups by polysomnography: (1) central sleep apnea, (2) mixed apnea, (3) no apnea and (4) obstructive sleep apnea. Fifty‐six subjects were included. Eighteen subjects were diagnosed with central sleep apnea, 15 with mixed apnea, 12 with obstructive apnea and 11 with no sleep apnea. Leptin concentration was significantly lower in central sleep apnea compared to obstructive apnea (8 ± 10.7 ng mL−1 versus 19.7 ± 14.7 ng mL−1, P ˂ 0.01) or no sleep apnea (8 ± 10.7 ng mL−1 versus 17.1 ± 8.4 ng mL−1, P ˂ 0.01). Logistic regression showed leptin to be associated independently with central sleep apnea [odds ratio (OR): 0.19; 95% confidence interval (CI): 0.06–0.62; area under the curve (AUC): 0.80, P < 0.01]. For the detection of central sleep apnea, a cut‐off value for leptin concentration 5 ng mL−1 yielded a sensitivity of 50% and specificity of 89%. In conclusion, a low leptin concentration may have utility for the screening of heart failure patients for central sleep apnea.
- 1 May 2017
- Published by Elsevier in Heart & Lung
- Vol. 46 (3) , 187-191
Sex differences in leptin modulate ventilation in heart failure
- 1 May 2017
- Published by Elsevier in Heart & Lung
- Vol. 46 (3) , 187-191
Sex differences in leptin modulate ventilation in heart failure
- 1 May 2015
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 21 (5) , 367-373
Modulation of Ventilatory Reflex Control by Cardiac Resynchronization Therapy
- 1 May 2015
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 21 (5) , 367-373
Modulation of Ventilatory Reflex Control by Cardiac Resynchronization Therapy
- 1 May 2014
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 20 (5) , 376-376.e14
Erratum